2. Duration of Therapy

Continuous, long-term use of topical calcineurin inhibitors should be avoided, and use should be confined only to areas affected by atopic dermatitis. Patients whose symptoms do not resolve following six weeks of calcineurin inhibitor therapy should be re-evaluated by their health care provider to confirm the diagnosis of atopic dermatitis^1-4.

Patients with a confirmed diagnosis of atopic dermatitis will require chronic, intermittent therapy for this condition. Patient profiles with either excessive prescriptions for calcineurin inhibitors during a 30-day time period (greater than 1 x 60 g tube) or without a definitive diagnosis of atopic dermatitis while prescribed a topical calcineurin inhibitor during a 90-day time period will be reviewed.